Registered bioimaging of nanomaterials for diagnostic and therapeutic monitoring

Michael Boska, Yutong Liu, Mariano Uberti, Balasrinivasa R Sajja, Shantanu Balkundi, JoEllyn M McMillan, Howard Eliot Gendelman

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Nanomedications can be carried by blood borne monocyte-macrophages into the reticuloendothelial system (RES; spleen, liver, lymph nodes) and to end organs. The latter include the lung, RES, and brain and are operative during human immunodeficiency virus type one (HIV-1) infection. Macrophage entry into tissues is notable in areas of active HIV-1 replication and sites of inflammation. In order to assess the potential of macrophages as nanocarriers, superparamagnetic iron-oxide and/or drug laden particles coated with surfactants were parenterally injected into HIV-1 encephalitic mice. This was done to quantitatively assess particle and drug biodistribution. Magnetic resonance imaging (MRI) test results were validated by histological coregistration and enhanced image processing. End organ disease as typified by altered brain histology were assessed by MRI. The demonstration of robust migration of nanoformulations into areas of focal encephalitis provides '"proof of concept" for the use of advanced bioimaging techniques to monitor macrophage migration. Importantly, histopathological aberrations in brain correlate with bioimaging parameters making the general utility of MRI in studies of cell distribution in disease feasible. We posit that using such methods can provide a real time index of disease burden and therapeutic efficacy with translational potential to humans.

Original languageEnglish (US)
Article numbere2459
JournalJournal of Visualized Experiments
Issue number46
DOIs
StatePublished - Dec 2010

Fingerprint

Nanostructures
Macrophages
Nanostructured materials
Magnetic resonance imaging
HIV-1
Brain
Monitoring
Magnetic Resonance Imaging
Mononuclear Phagocyte System
Histology
Encephalitis
Therapeutics
Aberrations
Iron oxides
Viruses
Surface-Active Agents
Pharmaceutical Preparations
Liver
HIV Infections
Monocytes

Keywords

  • Infectious Disease
  • Issue 46
  • Magnetic resonance imaging
  • Magnetic resonance spectroscopy
  • Mouse
  • Neuroimaging

ASJC Scopus subject areas

  • Neuroscience(all)
  • Chemical Engineering(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Registered bioimaging of nanomaterials for diagnostic and therapeutic monitoring. / Boska, Michael; Liu, Yutong; Uberti, Mariano; Sajja, Balasrinivasa R; Balkundi, Shantanu; McMillan, JoEllyn M; Gendelman, Howard Eliot.

In: Journal of Visualized Experiments, No. 46, e2459, 12.2010.

Research output: Contribution to journalArticle

@article{365885c9c36f488592840ed2917ee2be,
title = "Registered bioimaging of nanomaterials for diagnostic and therapeutic monitoring",
abstract = "Nanomedications can be carried by blood borne monocyte-macrophages into the reticuloendothelial system (RES; spleen, liver, lymph nodes) and to end organs. The latter include the lung, RES, and brain and are operative during human immunodeficiency virus type one (HIV-1) infection. Macrophage entry into tissues is notable in areas of active HIV-1 replication and sites of inflammation. In order to assess the potential of macrophages as nanocarriers, superparamagnetic iron-oxide and/or drug laden particles coated with surfactants were parenterally injected into HIV-1 encephalitic mice. This was done to quantitatively assess particle and drug biodistribution. Magnetic resonance imaging (MRI) test results were validated by histological coregistration and enhanced image processing. End organ disease as typified by altered brain histology were assessed by MRI. The demonstration of robust migration of nanoformulations into areas of focal encephalitis provides '{"}proof of concept{"} for the use of advanced bioimaging techniques to monitor macrophage migration. Importantly, histopathological aberrations in brain correlate with bioimaging parameters making the general utility of MRI in studies of cell distribution in disease feasible. We posit that using such methods can provide a real time index of disease burden and therapeutic efficacy with translational potential to humans.",
keywords = "Infectious Disease, Issue 46, Magnetic resonance imaging, Magnetic resonance spectroscopy, Mouse, Neuroimaging",
author = "Michael Boska and Yutong Liu and Mariano Uberti and Sajja, {Balasrinivasa R} and Shantanu Balkundi and McMillan, {JoEllyn M} and Gendelman, {Howard Eliot}",
year = "2010",
month = "12",
doi = "10.3791/2459",
language = "English (US)",
journal = "Journal of Visualized Experiments",
issn = "1940-087X",
publisher = "MYJoVE Corporation",
number = "46",

}

TY - JOUR

T1 - Registered bioimaging of nanomaterials for diagnostic and therapeutic monitoring

AU - Boska, Michael

AU - Liu, Yutong

AU - Uberti, Mariano

AU - Sajja, Balasrinivasa R

AU - Balkundi, Shantanu

AU - McMillan, JoEllyn M

AU - Gendelman, Howard Eliot

PY - 2010/12

Y1 - 2010/12

N2 - Nanomedications can be carried by blood borne monocyte-macrophages into the reticuloendothelial system (RES; spleen, liver, lymph nodes) and to end organs. The latter include the lung, RES, and brain and are operative during human immunodeficiency virus type one (HIV-1) infection. Macrophage entry into tissues is notable in areas of active HIV-1 replication and sites of inflammation. In order to assess the potential of macrophages as nanocarriers, superparamagnetic iron-oxide and/or drug laden particles coated with surfactants were parenterally injected into HIV-1 encephalitic mice. This was done to quantitatively assess particle and drug biodistribution. Magnetic resonance imaging (MRI) test results were validated by histological coregistration and enhanced image processing. End organ disease as typified by altered brain histology were assessed by MRI. The demonstration of robust migration of nanoformulations into areas of focal encephalitis provides '"proof of concept" for the use of advanced bioimaging techniques to monitor macrophage migration. Importantly, histopathological aberrations in brain correlate with bioimaging parameters making the general utility of MRI in studies of cell distribution in disease feasible. We posit that using such methods can provide a real time index of disease burden and therapeutic efficacy with translational potential to humans.

AB - Nanomedications can be carried by blood borne monocyte-macrophages into the reticuloendothelial system (RES; spleen, liver, lymph nodes) and to end organs. The latter include the lung, RES, and brain and are operative during human immunodeficiency virus type one (HIV-1) infection. Macrophage entry into tissues is notable in areas of active HIV-1 replication and sites of inflammation. In order to assess the potential of macrophages as nanocarriers, superparamagnetic iron-oxide and/or drug laden particles coated with surfactants were parenterally injected into HIV-1 encephalitic mice. This was done to quantitatively assess particle and drug biodistribution. Magnetic resonance imaging (MRI) test results were validated by histological coregistration and enhanced image processing. End organ disease as typified by altered brain histology were assessed by MRI. The demonstration of robust migration of nanoformulations into areas of focal encephalitis provides '"proof of concept" for the use of advanced bioimaging techniques to monitor macrophage migration. Importantly, histopathological aberrations in brain correlate with bioimaging parameters making the general utility of MRI in studies of cell distribution in disease feasible. We posit that using such methods can provide a real time index of disease burden and therapeutic efficacy with translational potential to humans.

KW - Infectious Disease

KW - Issue 46

KW - Magnetic resonance imaging

KW - Magnetic resonance spectroscopy

KW - Mouse

KW - Neuroimaging

UR - http://www.scopus.com/inward/record.url?scp=80355142410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80355142410&partnerID=8YFLogxK

U2 - 10.3791/2459

DO - 10.3791/2459

M3 - Article

C2 - 21178969

AN - SCOPUS:80355142410

JO - Journal of Visualized Experiments

JF - Journal of Visualized Experiments

SN - 1940-087X

IS - 46

M1 - e2459

ER -